/IBOGF

IBOGF Stock - Universal Ibogaine Inc.

Q: What is the analyst price target for IBOGF?

Analyst price target information is not currently available for IBOGF.

Q: What is IBOGF's market cap?

Market capitalization information is not currently available for IBOGF.

Healthcare|Biotechnology|OTC

$0.01+32.78%

+$0.00 (+32.78%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IBOGF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta5.51

52W High$0.10

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	$1.07M	N/A	N/A	N/A	N/A
Gross Profit	$1.07M	N/A	N/A	N/A	N/A
Gross Margin	100.0%	N/A	N/A	N/A	N/A
Operating Income	$497,151	$-3,833,064	$383	$-33,861	$63,952
Net Income	$-10,496,202	$-3,867,217	$-118,309	$-98,109	$-408,289
Net Margin	-980.2%	N/A	N/A	N/A	N/A
EPS	$-0.06	$-0.03	$-0.01	$-0.01	$-0.04

Company Overview

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.

Visit Website